Skip to main content
. 2024 Feb 1;103(4):103516. doi: 10.1016/j.psj.2024.103516

Table 4.

Antimicrobial resistance of 136 S. Infantis isolated from 58 commercial farms of 5 integrated broiler operations.

Antimicrobial agents No. of antimicrobial resistant S. Infantis isolates (%)
Environments
Dead chickens
Total
Prior to placement
At the time of depletion
Within 1 week old (n = 2) At 4–5 weeks old (n = 30) pESI-negative (n = 15) pESI-positive (n = 121)
Dust (n = 3)1 Dust (n = 40) Feces (n=61)
Amoxicillin-clavulanate 0 (0.0) 5 (12.5) 1 (1.6) 0 (0.0) 0 (0.0) 0 (0.0) 6 (5.0)
Ampicillin 1 (33.3)b 38 (95.0)a 52 (85.2)a,b 1 (50.0)d 29 (96.7)c 2 (13.3)B 119 (98.3)A
Cefazolin 1 (33.3)b 38 (95.0)a 50 (82.0)a,b 1 (50.0)d 29 (96.7)c 0 (0.0)B 119 (98.3)A
Cefepime 0 (0.0) 2 (5.0) 2 (3.3) 0 (0.0) 4 (13.3) 0 (0.0) 8 (6.6)
Cefotaxime 1 (33.3)b 37 (92.5)a 50 (82.0)a,b 1 (50.0)d 29 (96.7)c 0 (0.0)B 118 (97.5)A
Cefoxitin 0 (0.0) 7 (17.5) 11 (18.0) 0 (0.0) 4 (13.3) 1 (6.7) 21 (17.4)
Chloramphenicol 1 (33.3)b 36 (90.0)a 50 (82.0)a,b 1 (50.0)d 30 (100.0)c 2 (13.3)B 116 (95.9)A
Ciprofloxacin 0 (0.0) 3 (7.5) 2 (3.3) 0 (0.0) 1 (3.3) 0 (0.0) 6 (5.0)
Gentamicin 1 (33.3) 24 (60.0) 29 (47.5) 1 (50.0) 15 (50.0) 0 (0.0)B 70 (57.9)A
Imipenem 0 (0.0) 1 (2.5) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.8)
Nalidixic acid 3 (100.0) 38 (95.0) 56 (91.8) 2 (100.0) 30 (100.0) 9 (60.0)B 120 (99.2)A
Tetracycline 1 (33.3)b 37 (92.5)a 48 (78.7)a,b 1 (50.0)d 30 (100.0)c 0 (0.0)B 117 (96.7)A
Trimethoprim/sulfamethoxazole 1 (33.3) 28 (70.0) 37 (60.7) 0 (0.0)d 23 (76.7)c 0 (0.0)B 89 (73.6)A
MDR 1 (33.3)b 38 (95.0)a 51 (83.6)a,b 1 (50.0)d 30 (100.0)c 1 (6.7)B 120 (99.2)A
1

n = No. of S. Infantis isolated from 5 integrated broiler operations.

Values with different superscript letters (a, b or c, d) represent significant differences between environments or dead chickens, respectively, while subscript letters (A, B) represent significant differences between pESI-positive and pESI-negative S. Infantis (P < 0.05). Multidrug-resistance (MDR) was defined as resistance to 3 or more antimicrobial classes.